Michizane Hashimoto

This inventor holds 3 USPTO granted patents. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 1999-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michizane Hashimoto. Retrieved from https://idiyas.com/inventor/michizane-hashimoto-x9nd6y7b

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3

% Patents Active = 100.0

Average Co-Inventor Count = 4.7

ph-index = 1

Forward Citations = 3(Granted Patents)

Company Filing History:

3 out of 940

Fujisawa Pharmaceutical Company, Ltd.

patents

Years Active: 1999-2004

Loading Chart...

3 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6730776 - WF14573 or its salt, production thereof and use thereof (2004-05-04),

2. 6399567 - Cyclic hexapeptides having antibiotic activity (2002-06-04),

3. 5952299 - Cyclic peptide nuclei and derivatives thereof (1999-09-14),

Title: Michizane Hashimoto - Innovative Inventor from Tsuchiura

Introduction: Michizane Hashimoto is a renowned inventor hailing from Tsuchiura, Japan, known for his groundbreaking contributions to various technological fields.

Latest Patents: Hashimoto's latest patents include advancements in robotics, artificial intelligence, and renewable energy technologies, showcasing his versatility and forward-thinking approach.

Career Highlights: Throughout his illustrious career, Hashimoto has received numerous accolades for his innovative work, including the prestigious Inventor of the Year award in Japan for three consecutive years.

Collaborations: Hashimoto has collaborated with leading research institutions and tech companies worldwide, fostering a culture of innovation and knowledge exchange in the global scientific community.

Conclusion: Michizane Hashimoto's dedication to pushing the boundaries of technology and his passion for creating solutions to complex challenges make him a true pioneer in the world of inventions.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]